Pfizer and BioNTech said Friday that a COVID-19 vaccine could be developed and produced within 100 days to counter a "vaccine-escape" variant like B.1.1.529.
Pfizer and BioNTech said Friday that a COVID-19 vaccine could be developed and produced within 100 days to counter a "vaccine-escape" variant like B.1.1.529.